Andreas Schulte-Mecklenbeck

22PUBLICATIONS
101CO-AUTHORS
Medical infection agents (incl. prions)AutoimmunityHaematological tumoursRespiratory diseasesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 14, 2026
A CSF disease-associated macrophage signature defines progressive multiple sclerosis.

|Apr 30, 2025
Lymphocyte signatures correspond to clinical phenotypes in autoimmune limbic encephalitis.

Saskia Räuber, Andreas Schulte-Mecklenbeck, Kelvin Sarink

|Apr 03, 2025
Suboptimal B-cell depletion is associated with progression independent of relapse activity in multiple sclerosis patients treated with ocrelizumab.

Lisa Revie, Annika Jürjens, Maria Eveslage

|Mar 27, 2024
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.

Catharina C Gross, Andreas Schulte-Mecklenbeck, Olga V Steinberg

|Feb 24, 2023
Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry.

Michael Heming, Louisa Müller-Miny, Leoni Rolfes

|Dec 27, 2022
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.

Claudia Janoschka, Maren Lindner, Nils Koppers

Pageof 4

Frequent Collaborators

8 joint publications

Catharina C Gross

8 joint publications

Nicholas Schwab

7 joint publications

Tilman Schneider-Hohendorf

6 joint publications

Gerd Meyer Zu Horste